









市場行情
/
股票
/
nasdaq-axgn
/

AxoGen Inc

AXGN

31.980USD

+0.280+0.88%

收盤 12/19, 16:00（美東）報價延遲15分鐘

1.47B總市值

虧損本益比TTM



AxoGen Inc

31.980

+0.280+0.88%

概覽公司財務分析

概覽

公司

財務

分析

關於 AxoGen Inc 公司

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc簡介



公司代碼AXGN

公司名稱AxoGen Inc

上市日期Dec 17, 1986

CEODale (Michael Donald)

員工數量451

證券類型Ordinary Share

年結日Dec 17

公司地址13631 Progress Blvd.

城市ALACHUA

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編32615

電話13864626817

網址https://www.axogeninc.com/

公司代碼AXGN

上市日期Dec 17, 1986

CEODale (Michael Donald)

AxoGen Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Erick Wayne Devinney

Chief Innovation Officer

172.26K

+13.50%

Ms. Lindsey Hartley

Chief Financial Officer

31.38K

+51.11%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

27.03K

+113.10%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

Mr. Paul G. Thomas

Independent Chairman of the Board

-100.00%

Mr. John H. Johnson

Independent Director

Ms. Kathy Weiler

Independent Director

Mr. Marc A. Began

Executive Vice President, Chief Compliance Officer, General Counsel

Mr. William P. (Bill) Burke

Independent Director

Mr. Alan M. Levine

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Erick Wayne Devinney

Chief Innovation Officer

172.26K

+13.50%

Ms. Lindsey Hartley

Chief Financial Officer

31.38K

+51.11%

Mr. Jens Schroeder Kemp

Chief Marketing Officer

27.03K

+113.10%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

Mr. Paul G. Thomas

Independent Chairman of the Board

-100.00%

Mr. John H. Johnson

Independent Director

收入明細

FY2023

FY2022

由於公司未披露，未能獲取相關數據

地區USD

名稱

營收

佔比

United States

159.01M

0.00%

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 11月15日週六

持股股東

股東類型

持股股東

佔比

First Light Asset Management, LLC

12.59%

BlackRock Institutional Trust Company, N.A.

6.89%

The Vanguard Group, Inc.

5.79%

Morgan Stanley & Co. LLC

4.96%

ArrowMark Colorado Holdings, LLC

4.25%

其他

65.53%

持股股東

佔比

First Light Asset Management, LLC

12.59%

BlackRock Institutional Trust Company, N.A.

6.89%

The Vanguard Group, Inc.

5.79%

Morgan Stanley & Co. LLC

4.96%

ArrowMark Colorado Holdings, LLC

4.25%

其他

65.53%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

40.33%

Investment Advisor

29.37%

Hedge Fund

14.38%

Research Firm

6.35%

Individual Investor

5.37%

Family Office

1.76%

Bank and Trust

0.35%

Pension Fund

0.33%

Sovereign Wealth Fund

0.13%

其他

1.63%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

342

42.08M

97.83%

+8.74K

2025Q3

350

42.06M

101.71%

+627.35K

2025Q2

344

41.40M

98.61%

+1.26M

2025Q1

339

40.15M

93.21%

-2.27M

2024Q4

327

37.35M

99.16%

-1.08M

2024Q3

305

37.98M

92.55%

+3.00M

2024Q2

285

37.71M

96.69%

+1.44M

2024Q1

290

36.54M

95.40%

-4.68M

2023Q4

299

34.97M

92.73%

+437.14K

2023Q3

304

34.60M

92.75%

-2.09M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

First Light Asset Management, LLC

4.53M

9.84%

+55.03K

+1.23%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

3.10M

6.74%

-26.22K

-0.84%

Jun 30, 2025

The Vanguard Group, Inc.

2.72M

5.92%

+191.79K

+7.58%

Jun 30, 2025

Morgan Stanley & Co. LLC

1.93M

4.2%

+348.58K

+21.98%

Jun 30, 2025

ArrowMark Colorado Holdings, LLC

1.63M

3.53%

+34.80K

+2.19%

Jun 30, 2025

Soleus Capital Management, L.P.

1.46M

3.17%

+13.28K

+0.92%

Jun 30, 2025

Wasatch Global Investors Inc

1.43M

3.12%

+659.15K

+85.09%

Jun 30, 2025

Balyasny Asset Management LP

1.93M

4.2%

+1.25M

+183.91%

Jun 30, 2025

Assenagon Asset Management S.A.

1.29M

2.8%

+265.95K

+25.99%

Sep 30, 2025

Armistice Capital LLC

1.11M

2.42%

+573.04K

+106.46%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

ROBO Global Healthcare Technology & Innovation ETF

3.51%

State Street SPDR S&P Health Care Equipment ETF

2.3%

iShares Neuroscience and Healthcare ETF

2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

0.97%

Invesco NASDAQ Future Gen 200 ETF

0.74%

JPMorgan Fundamental Data Science Small Core ETF

0.21%

iShares Micro-Cap ETF

0.19%

Fidelity Enhanced Small Cap ETF

0.18%

Principal U.S. Small-Cap ETF

0.15%

Franklin US Small Cap Multifactor Index ETF

0.14%

ROBO Global Healthcare Technology & Innovation ETF

佔比3.51%

State Street SPDR S&P Health Care Equipment ETF

佔比2.3%

iShares Neuroscience and Healthcare ETF

佔比2.11%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比0.97%

Invesco NASDAQ Future Gen 200 ETF

佔比0.74%

JPMorgan Fundamental Data Science Small Core ETF

佔比0.21%

iShares Micro-Cap ETF

佔比0.19%

Fidelity Enhanced Small Cap ETF

佔比0.18%

Principal U.S. Small-Cap ETF

佔比0.15%

Franklin US Small Cap Multifactor Index ETF

佔比0.14%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

AxoGen Inc的前五大股東是誰？



AxoGen Inc的前五大股東如下：
First Light Asset Management, LLC
持有股份：4.53M
佔總股份比例：9.84%。
BlackRock Institutional Trust Company, N.A.
持有股份：3.10M
佔總股份比例：6.74%。
The Vanguard Group, Inc.
持有股份：2.72M
佔總股份比例：5.92%。
Morgan Stanley & Co. LLC
持有股份：1.93M
佔總股份比例：4.20%。
ArrowMark Colorado Holdings, LLC
持有股份：1.63M
佔總股份比例：3.53%。